Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 13/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.39 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30279291 | 0.91 | REN (0.43) | RENDPP7MEN1KMT2A | |
| SCHEMBL30050989 | 0.88 | DPP7 (0.44) | RENDPP7MEN1KMT2A | |
| SCHEMBL29655844 | 0.87 | REN (0.43) | RENDPP7CALCRLMEN1KMT2A | |
| SCHEMBL30279372 | 0.86 | REN (0.54) | REN | |
| SCHEMBL30051614 | 0.84 | L3MBTL1 (0.45) | RENDPP7CALCRLMEN1KMT2A | |
| SCHEMBL30051707 | 0.84 | L3MBTL1 (0.47) | RENDPP7MEN1KMT2A | |
| SCHEMBL29599516 | 0.81 | CALCRL (0.41) | RENDPP7CALCRLMEN1KMT2A | |
| SCHEMBL30974413 | 0.80 | REN (0.45) | RENCALCRLMAPK8MAPK9MAPK10 | |
| SCHEMBL7752530 | 0.80 | BACE1 (0.49) | RENCALCRLMEN1KMT2AMAPK8 | |
| SCHEMBL7752521 | 0.80 | BACE1 (0.49) | RENCALCRLMEN1KMT2AMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115477685-A | Application of selenium-containing polypeptide compound in preparation of antibacterial drugs | 浙江工业大学 | 2022-12-16 | — | — | CN | disclosed |